Praxis Precision Medicines Inc (PRAX) Stock Price & News

PRAX:NASDAQ

Praxis Precision Medicines Inc

$259.86

-1.40%

(-3.69) 1D

$259.86

0.00% (0.00)

After hours

Closed: Oct 9, 4:00:00 PM GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for PRAX...

Open

$266.91

High

$267.85

Low

$259.00

Mkt. cap

7.26B

Avg. vol.

431.28K

Volume

517.23K

52-wk high

$392.70

52-wk low

$50.56

EPS

-$12.93

Beta

2.79

Shares outstanding

27.92M

No. of employees

168

Open

$266.91

High

$267.85

Low

$259.00

Mkt. cap

7.26B

Avg. vol.

431.28K

Volume

517.23K

52-wk high

$392.70

52-wk low

$50.56

EPS

-$12.93

Beta

2.79

Shares outstanding

27.92M

No. of employees

168

Related stocks

RVMD

Revolution Medicines Inc

$189.76

+0.87%

SYRE

Spyre Therapeutics Inc

News stories

From web sources and news partners

https://www.dars.gov.et/

1 week ago

PRAX Q2 2026 Earnings: Narrower-Than-Expected Loss as Clinical-Stage Biotech Curbs Spending - Guidance Update

https://www.dars.gov.et/

1 month ago

Praxis Precision Medicines (PRAX) Climbs 1.23% as Shares Press Toward $375.69 Resistance - CTA Positioning

About Praxis Precision Medicines Inc

CEO-

Employees168

Founded2015

HeadquartersBoston, Massachusetts, United States

SectorBiotechnology

Websitepraxismedicines.com

Analyst	Recommendation	Action	Price target	Projected	Date
Kambiz Yazdi BTIG	Buy	Reiterated	$826.00	+217.9%	10/06/2026
Douglas Tsao H.C. Wainwright	Buy	Maintained	$1,201.00	+362.2%	10/05/2026
Justin Walsh JonesTrading	Buy	Reiterated	$534.00	+105.5%	10/01/2026
Ami Fadia Needham	Buy	Reiterated	$582.00	+124%	09/24/2026
Kevin Strang Goldman Sachs	Buy	Reiterated	$575.00	+121.3%	08/21/2026
Jay Olson Oppenheimer	Buy	Reiterated	$650.00	+150.1%	08/17/2026
Tiago Fauth Raymond James	Buy	Maintained	$945.00	+263.7%	08/17/2026
Yasmeen Rahimi Piper Sandler	Buy	Maintained	$1,200.00	+361.8%	08/07/2026
Danielle Brill Truist Financial	Buy	Maintained	$616.00	+137.1%	08/07/2026
Yatin Suneja Guggenheim	Buy	Reiterated	$800.00	+207.9%	08/06/2026
Brian Skorney Robert W. Baird	Buy	Maintained	$514.00	+97.8%	08/07/2026
Leonid Timashev RBC Capital	Buy	Reiterated	$462.00	+77.8%	08/06/2026
Benjamin Burnett Wells Fargo	Hold	Maintained	$362.00	+39.3%	08/07/2026
Ritu Baral TD Cowen	Buy	Maintained	$510.00	+96.3%	08/06/2026
Francois Brisebois LifeSci Capital	Buy	Reiterated	$754.00	+190.2%	08/08/2026
Andrew Tsai Jefferies	Buy	Maintained	$550.00	+111.7%	06/30/2026
Laura Chico Wedbush	Sell	Maintained	$162.00	-37.7%	06/02/2026
David Hoang Deutsche Bank	Buy	Maintained	$374.00	+43.9%	06/02/2026
Joon Lee Truist Financial	Buy	Initiated	$715.00	+175.1%	05/13/2026
Unknown Analyst Raymond James	Buy	Initiated	$815.00	+213.6%	04/08/2026
Rudy Li Wolfe Research	Buy	Maintained	$500.00	+92.4%	04/06/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	65.80M	77.51M	77.99M	69.42M
Cost of revenue	65.80M	77.51M	77.99M	69.42M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12.56M	19.54M	27.87M	27.49M
Operating expense	12.56M	19.54M	27.87M	27.49M
Total operating expenses	78.36M	97.04M	105.86M	96.90M
Operating income	-78.36M	-97.04M	-105.86M	-96.90M
Other non operating income	-	-	-	-
EBT including unusual items	-73.93M	-88.91M	-92.56M	-83.72M
EBT excluding unusual items	-73.93M	-92.50M	-93.22M	-83.72M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-73.93M	-88.91M	-92.56M	-83.72M
Net profit margin	-	-	-	-
Earnings per share	-3.36	-3.50	-3.20	-2.87
Interest and investment income	4.42M	4.54M	12.64M	13.18M
Interest expense	-	-	-	-
Net interest expenses	4.42M	4.54M	12.64M	13.18M
Depreciation and amortization charges	-	-	-	-
EBITDA	-78.34M	-97.02M	-105.82M	-96.87M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything